Lamivudine And Tenofovir Disoproxil Fumarate Tablets

Get a Price/Quote

Product Details:

Usage Taken orally as prescribed by a healthcare professional
Appearance White to off-white tablets
Expiration Date 24 months from the date of manufacture
Storage Store below 30°C protect from light and moisture
CAS No 134678-17-4 (Lamivudine) 202138-50-9 (Tenofovir Disoproxil Fumarate)
Assay Not less than 98% purity for both active ingredients
Molecular Formula Lamivudine (C8H11N3O3S) Tenofovir Disoproxil Fumarate (C19H30N5O10P·C4H4O4)
Click to view more
Share Your Product:

Request To Call Back Send Inquiry

Lamivudine And Tenofovir Disoproxil Fumarate Tablets Product Specifications

CAS No 134678-17-4 (Lamivudine) 202138-50-9 (Tenofovir Disoproxil Fumarate)
Appearance White to off-white tablets
Usage Taken orally as prescribed by a healthcare professional
Expiration Date 24 months from the date of manufacture
Storage Store below 30°C protect from light and moisture
Origin of Medicine Synthetic
Dosage Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg per tablet
Indication Used for the treatment of HIV-1 infection in adults and adolescents
Assay Not less than 98% purity for both active ingredients
Molecular Formula Lamivudine (C8H11N3O3S) Tenofovir Disoproxil Fumarate (C19H30N5O10P·C4H4O4)
Pacakaging (Quantity Per Box) 30 tablets per box
Medicine Type Antiretroviral
Grade Pharmaceutical Grade
Dosage Form Tablets
Salt Composition Lamivudine Tenofovir Disoproxil Fumarate

Product Description

Lamivudine and Tenofovir Disoproxil Fumarate Tablets are pharmaceutical-grade antiretroviral tablets used for the treatment of HIV-1 infection in adults and adolescents. Each tablet contains Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg. The white to off-white tablets have a purity of not less than 98% for both active ingredients. These tablets are taken orally as prescribed by a healthcare professional and come in a packaging size of 30 tablets per box with an expiration date of 24 months from the date of manufacture. The salt composition includes Lamivudine and Tenofovir Disoproxil Fumarate, with a synthetic origin.

Packaging Size	30 Tablets Bottle
Brand	Tenvir L
Manufacturer	Cipla Ltd
Composition	Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg)
Treatment	HIV / AIDS
Prescription/Non prescription	Prescription

FAQs of Lamivudine And Tenofovir Disoproxil Fumarate Tablets:

Q: What is the dosage form of Lamivudine and Tenofovir Disoproxil Fumarate Tablets?

A: The dosage form of Lamivudine and Tenofovir Disoproxil Fumarate Tablets is in the form of tablets.

Q: What is the recommended dosage of these tablets?

A: The recommended dosage is Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg per tablet.

Q: How should these tablets be stored?

A: These tablets should be stored below 30C, protected from light and moisture.

Q: What is the indication for using Lamivudine and Tenofovir Disoproxil Fumarate Tablets?

A: These tablets are used for the treatment of HIV-1 infection in adults and adolescents.

Q: Who is the manufacturer of Tenvir L tablets?

A: Tenvir L tablets are manufactured by Cipla Ltd.

Other Products in 'HIV Medicine' category

Lopinavir And Ritonavir Tablets Dosage : As prescribed by the healthcare professional Origin of Medicine : Synthetic Indication : Treatment of HIV1 infection in combination with other antiretroviral agents Pacakaging (Quantity Per Box) : 30 tablets per box Salt Composition : Lopinavir 200mg + Ritonavir 50mg Dosage Form : Tablet Medicine Type : Antiretroviral Grade : Pharmaceutical Grade CAS No : 192725170 (Lopinavir) 155213675 (Ritonavir) Usage : Oral administration for viral suppression Appearance : White or offwhite tablets Storage : Store at 20°C to 25°C (68°F to 77°F) protect from moisture and light Expiration Date : 36 months from the date of manufacturing Assay : Lopinavir: 200mg Ritonavir: 50mg Molecular Formula : Lopinavir: C37H48N4O5 Ritonavir: C37H48N6O5S2

Send Inquiry

Nevirapine 200 Mg Tablet Dosage : 200 mg Origin of Medicine : Synthetic Indication : HIV treatment Pacakaging (Quantity Per Box) : 10x10 Tablets Salt Composition : Nevirapine 200 mg Dosage Form : Tablet Medicine Type : Antiviral Grade : Pharmaceutical CAS No : 129618402 Usage : Administered orally for the treatment of HIV1 infection Appearance : White to offwhite tablet Storage : Store below 25°C in a dry place away from light Expiration Date : 2 years from the date of manufacture Assay : Not less than 99% Nevirapine Molecular Formula : C15H14N4O

Send Inquiry

Lamivudine Stavudine And Nevirapine Tablets Dosage : As directed by the physician Origin of Medicine : Synthetic Indication : Treatment of HIV1 infection Pacakaging (Quantity Per Box) : 30 tablets per box Salt Composition : Lamivudine Stavudine Nevirapine Dosage Form : Tablet Medicine Type : Antiviral Grade : Pharmaceutical Grade CAS No : 134678174; 3056175; 129618402 Usage : Used in combination therapy for managing HIV/AIDS Appearance : White to offwhite tablet Storage : Store below 25°C in a dry place protected from light Expiration Date : 24 months from manufacturing date Assay : Lamivudine 150mg Stavudine 30mg Nevirapine 200mg Molecular Formula : C8H11N3O3; C10H12N2O4; C15H14N4O4

Send Inquiry

Sofosbuvir 400 Mg Velpatasvir 100mg Tablets Dosage : Sofosbuvir 400 mg + Velpatasvir 100 mg Origin of Medicine : Synthetic Indication : Treatment of chronic Hepatitis C infection Pacakaging (Quantity Per Box) : 28 Tablets Salt Composition : Sofosbuvir + Velpatasvir Dosage Form : Tablet Medicine Type : Antiviral Grade : Pharmaceutical Grade CAS No : 1190307880 (Sofosbuvir) 1377049847 (Velpatasvir) Usage : To inhibit viral replication and cure Hepatitis C infection Appearance : Filmcoated tablets Storage : Store below 30°C protect from moisture Expiration Date : 24 months from the date of manufacture Assay : Sofosbuvir Not Less Than 98% Velpatasvir Not Less Than 98% Molecular Formula : C22H29FN3O9P (Sofosbuvir) C49H54F2N8O8 (Velpatasvir)

Send Inquiry

SEND INQUIRY CALL ME FREE